Proteomics

Gain deeper insight into the proteome

Protein biomarker discovery can help bridge the gap between genomes and phenotypes, allowing improved understanding of real-time human biology and a stronger grasp of the transition from health to disease.  Performed by industry experts with specialization in proteomics, Discovery Life Sciences offers customizable proteomic services enabling a comprehensive understanding of the proteome and accelerating drug and diagnostic development programs.

Mass Spectrometry

Targeted and untargeted mass spectrometry with a wide range of workflow options

Multiplexed Immunoassays

Robust immunoassays that deliver unmatched coverage and reproducibility

Proteogenomics

Deep unbiased proteogenomics through integration of proteomic and genomic services

Multi-omic Studies

Integrated NGS, cell biology, and pathology services with expert bioinformatic support

Previous

Our goal is to propel proteomics over the threshold to full adoption in the drug discovery pipeline. We deliver actionable biomarker data integrated with our existing genomics, IHC, and flow cytometry services to better meet our clients’ needs and help guide their precision programs.

Michael Pisano

EVP, Proteomics, Discovery Life Sciences

Next

Single strategic partner for biospecimens and biomarker discovery

Image

Over 10 Million
Biospecimens

Image

Hundreds of
Clinical Sites
Globally

Image

PROTEOGENOMICS
& Bioinformatics

Image

Over 20 Years of
Expertise in
Pathology

Image

Full-service
Cell Biology
Laboratories

Image

GMP-compliant
Cell & Gene Therapy
Solutions

To propel your projects with The Power of Discovery.™

Contact Us Today

Let us know about your project!

Image